Actionable MRD in breast cancer: What to do after a positive ctDNA result

Upcoming webinar

Actionable MRD in breast cancer:

What to do after a positive ctDNA result

Date: Tuesday, October 27, 2026

Time: 4:00 PM CT (45-minute webinar)

Registrants will receive a recording of the webinar approximately one week after the event.

Join Dr. Prakash Peddi for a focused presentation on real-world evidence (RWE) and patient case studies demonstrating how to translate positive ctDNA / MRD test results into actionable clinical management strategies for breast cancer patients.

Key takeaways include:

Post-treatment risk stratification
Clinical decision-making
Navigating positive Signatera™ findings in everyday practice

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Hear from our speaker:

Dr. Prakash Peddi

Dr. Prakash Peddi is a medical oncologist and hematologist at Willis Knighton Health, specializing in breast cancer and clinical research.

He is dedicated to advancing patient care through personalized treatment strategies,

innovative therapeutic approaches, and ongoing clinical trials in precision oncology.

Signatera™ has been developed and its performance characteristics determined by the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy